Monarch PCM, LLC is recalling 15,730 bottles of Phenobarbital Elixir (20 mg/5 mL) because the product contains alcohol levels that exceed required USP specifications. This prescription medication, sold under the Westminster Pharmaceuticals brand, is used to treat seizures and for sedation but was found to have incorrect alcohol concentrations during testing. No injuries or adverse events have been reported to date, but consumers should consult their healthcare provider regarding any concerns.
The higher-than-specified alcohol content may cause unexpected side effects or drug interactions, particularly in patients sensitive to alcohol or those taking other central nervous system depressants. Excessive alcohol in a sedative medication can increase the risk of drowsiness, respiratory depression, or altered mental status.
You have 2 options:
Recall #: D-0878-2022. Quantity affected: 15,730 bottles.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.